CareTrust REIT (CTRE) Margin Surge Reinforces Bullish Narratives Ahead Of FY 2025 Earnings
CareTrust REIT, Inc. CTRE | 0.00 |
CareTrust REIT (CTRE) has wrapped up FY 2025 with fourth quarter revenue of US$134.9 million and basic EPS of US$0.50, setting the tone for a year where trailing twelve month revenue reached US$476.4 million and EPS came in at US$1.57. Over the past six reported quarters, revenue has moved from US$77.4 million in Q3 2024 to US$134.9 million in Q4 2025, while quarterly basic EPS has ranged from US$0.21 to US$0.50. This leaves investors focused on how these headline figures line up with the strong margin profile highlighted in the trailing 12 month net profit margin of 67.3%.
See our full analysis for CareTrust REIT.With the latest numbers on the table, the next step is to set these results against the most common narratives around CareTrust REIT and see which stories the data supports and which ones start to look stretched.
67.3% margin puts FFO and EPS in focus
- Across the last 12 months, CareTrust REIT reported net income of US$320.5 million on revenue of US$476.4 million, which equates to a 67.3% net profit margin versus 42.2% a year earlier.
- Analysts' consensus view highlights that this high margin is supported by expansion into U.S. and U.K. seniors housing and healthcare properties and strong operator relationships, yet they also flag that rapid portfolio growth and higher G&A could pressure profitability.
- The consensus narrative ties the U.K. care home entry and the Care REIT acquisition to future rent streams, while the data reminds you that upfront investments in talent and systems are already contributing to a 156.3% earnings growth figure that may not repeat in the same way.
- With trailing 12 month revenue growth running at about 17.1% a year and current margins at 67.3%, the key question for this bullish view is whether added costs from integration and new markets leave margins closer to the 53.3% level analysts expect in a few years.
DCF fair value of US$89.41 vs US$39.50 price
- The supplied DCF fair value of US$89.41 sits well above the current share price of US$39.50, while the trailing P/E of 27.5x is below the 63.5x peer average but above the 24.2x Global Health Care REITs industry figure.
- Bears argue that rapid expansion and equity issuance can lead to weaker per share economics, and the data around dilution and dividend coverage keeps that cautious view in play.
- Shareholders were diluted over the past year and earnings are flagged as not fully covering the 3.39% dividend yield, which challenges the idea that a large gap to the DCF fair value automatically signals an easy valuation upside.
- With analysts targeting US$43.67 and forecasting earnings growth around 11.6% a year, skeptics point out that the margin of safety implied by the DCF fair value can narrow quickly if growth or margins track closer to those more moderate forecasts.
Dividend at 3.39% with forecast 11.6% earnings growth
- The data pairs a 3.39% dividend yield with earnings that are not fully covering that payout over the last 12 months, while analysts expect earnings to grow around 11.6% a year and revenue about 17.1% a year.
- Consensus narrative supporters point to a roughly US$600 million external investment pipeline and exposure to growing senior care demand as reasons the dividend could remain supported by future cash flows, yet the current coverage gap shows why income focused investors still need to watch funding and payout ratios closely.
- The focus on skilled nursing, seniors housing and U.K. care homes is cited as a driver of FFO over time, but the same data also notes that analysts expect profit margins to be lower than 67.3% in a few years, which would influence room for dividends and reinvestment.
- With analysts expecting shares outstanding to grow 7% per year, future dividend checks are tied not just to portfolio growth but also to how much of that 11.6% earnings growth translates into per share figures after dilution.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for CareTrust REIT on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Seeing both the risks and the rewards laid out together, it is worth taking a closer look at the data yourself and forming a view while the details are fresh in mind. You can start with the 3 key rewards and 2 important warning signs.
See What Else Is Out There
CareTrust REIT’s high margin sits beside dilution, limited dividend coverage and questions over how much forecast earnings growth will translate into per share results.
If you are uneasy about those pressures on income reliability and share count, it is worth checking out 12 dividend fortresses right now to compare options with stronger payout support.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
